entertainment -WSS

entertainment

author：comprehensive 2025-10-01 15:29:01 - browse：156

Rod Nathan, Ali Urman, and Patrick Nosker on the 2024 Breakthrough Summit East stage. — From left, Rod Nathan, portfolio manager and partner of J. Goldman & Co.; ARK Invest senior analyst Ali Urman; and Patrick Nosker, director of research and partner at Affinity Asset Advisors, discuss biotech investment opportunities at the 2024 STAT Breakthrough Summit East. STAT

Following a blockbuster year of dealmaking and a recent uptick in biotech stocks, top investors see more good news on the horizon.

Driving the momentum? Economics 101.

Biotechs rely on borrowing capital, which is a more tenuous task when interest rates are high. But interest rates have most likely peaked, with Federal Reserve officials signaling earlier this week they expected to make three cuts this year. For public biotechnology startups that have been battered by the market in recent years, this is a very good thing, Rod Nathan, portfolio manager and partner of J. Goldman & Co., said on a panel at STAT’s Breakthrough Summit East in New York on Thursday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Hospitals use virtual reality to design more inclusive rooms for kids

hotspot

WSS

More regulation could be coming for drug ads

Morphosys mixed study results for blood cancer drug

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Wegovy cuts risk of cardiovascular events by 20%, study finds

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

focus

entertainment

focus

The high cost of giving birth even with insurance

Poor hospice wound care hurts patients and families

Guidelines to prevent youth baseball injuries need more muscle

Lessons Learned: This is why you network to find that industry job you want

Sports medicine is finally prioritizing gender equality

FDA's Woodcock to retire early next year

Virginia high school admissions case could be legal follow

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

23andMe had bad news about my health. I wish a person had delivered it

A daunting task: navigating dual Medicare, Medicaid eligibility

hotspot

NYU radiologists take on the challenge of expensive MRI machines

PBM reforms clear House panel

CRISPR pioneers react to Casgevy, first gene

Lessons Learned: This is why you network to find that industry job you want

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Morphosys mixed study results for blood cancer drug

hotspot

leisure time

entertainment

focus